• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. A Review of Novel Corona Virus Disease (SARS-CoV-2)

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

A Review of Novel Corona Virus Disease (SARS-CoV-2)

    Authors

    • Anu Kumar
    • Navdeep Arora
    • Sushant Yadav

    University Institute of Biotechnology, Chandigarh University, Gharuan, Mohali -140413, Punjab, Indi

,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

The coronavirus (CoV-19) is exceedingly virulent and disease-causing infection produced by Severe Acute Respiratory Syndrome which is developed in China (Wuhan) and then expended globally. In the evolutionary examination declared that SARS CoV-2 and SARS-CoV are phylogenetically similar to each other while both were belonging to same family, same entry receptor ACE2 and both have common reservoir for viral infection and rapidly spread by the physical contact of suspected person to healthy person. The no. of cases of infected persons increased globally yet not controlled but still there clinically affirmed antiviral medicines have been check out against coronavirus disease. The structural examination of spike proteins and ACE2 receptors further subgroups properly explains the protocol of viral transmission a) alpha, b) beta, c) gamma, d) delta. International committee on taxonomy of viruses (ICTV) named novel virulent infection as SARS-CoV2 as virus and covid-19 as disease. SARS-CoV2 infected patients are of two types asymptomatic and symptomatic, both were capable to transfer the virus from infected individual to healthy individual and disease risk is not same for the all-age groups. We survey the comparison of SARS-CoV and SARS-COV2, Characteristics of coronavirus, molecular characteristics of SARA-CoV2, mechanism of entry, transmission and precautions. We also discussed therapeutic combination and effective drugs used to slow down or overcome with the covid-19 pandemic. At last, 80% infected patients were properly recovered from this viral infection covid-19 without any clinical consideration they recover with their own strong immunity and fight against infection.

Keywords

  • SARS-CoV-2
  • SARS-CoV
  • Virulent Infection
  • ACE-2 Receptor
  • XML
  • PDF 534.93 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 226
    • PDF Download: 325
European Journal of Molecular & Clinical Medicine
Volume 7, Issue 7
November 2020
Page 4695-4709
Files
  • XML
  • PDF 534.93 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 226
  • PDF Download: 325

APA

Kumar, A., Arora, N., & Yadav, S. (2020). A Review of Novel Corona Virus Disease (SARS-CoV-2). European Journal of Molecular & Clinical Medicine, 7(7), 4695-4709.

MLA

Anu Kumar; Navdeep Arora; Sushant Yadav. "A Review of Novel Corona Virus Disease (SARS-CoV-2)". European Journal of Molecular & Clinical Medicine, 7, 7, 2020, 4695-4709.

HARVARD

Kumar, A., Arora, N., Yadav, S. (2020). 'A Review of Novel Corona Virus Disease (SARS-CoV-2)', European Journal of Molecular & Clinical Medicine, 7(7), pp. 4695-4709.

VANCOUVER

Kumar, A., Arora, N., Yadav, S. A Review of Novel Corona Virus Disease (SARS-CoV-2). European Journal of Molecular & Clinical Medicine, 2020; 7(7): 4695-4709.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus